STAT June 8, 2023
Damian Garde and Meg Tirrell and Adam Feuerstein

Are drug prices protected by the Constitution? Will Medicare embrace Alzheimer’s disease treatments? And should lawyers be allowed to use thesauruses?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. STAT Washington correspondent Rachel Cohrs joins us to explain Merck’s lawsuit against the federal government and why the company believes drug pricing negotiation is “tantamount to extortion.” We also discuss the health effects of Canadian wildfires, the highlights of the year’s biggest cancer research conference, and what could be...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Pharma / Biotech, Trends
How digital health companies are capitalizing on the GLP-1 boom
Journalists Zero In on Bird Flu and Weight Loss Drugs
GLP-1 Agonists in Adolescents and Young Adults; Benefits of Cancer Drug Trials
Chasing the alchemy of trial diversity with a mix of culture change and practical mechanics
Ozempic Drug Semaglutide Could Protect Kidneys, Study Finds

Share This Article